nach oben

16.05.2024 | Original Article

Dysphagia in Head and Neck Radiotherapy: The Influence of Pharyngeal Constrictor Anatomy and Dosimetry

verfasst von: Owen Paetkau, Sarah Weppler, Jaime Kwok, Harvey C. Quon, Wendy Smith, Ekaterina Tchistiakova, Charles Kirkby

Erschienen in: Dysphagia

Einloggen, um Zugang zu erhalten

Abstract

The goal of this study was to identify which anatomical and dosimetric changes correlated with late patient-reported dysphagia throughout the course of head and neck chemo-radiotherapy treatment. The patient cohort (n = 64) considered oropharyngeal and nasopharyngeal patients treated with curative intent, exhibiting no baseline dysphagia with a follow-up time greater than one year. Patients completed the MD Anderson Dysphagia Inventory during a follow-up visit. A composite score was measured ranging from 20 to 100, with a low score indicating a high symptom burden; a score ≤60 indicated patient-reported dysphagia. The pharyngeal (PCM) and cricopharyngeal constrictor muscles (CPM) were contoured on a planning CT image and adapted to weekly cone-beam CT anatomy using deformable image registration and dose was accumulated using weighted dose-volume histogram curves. The PCM and CPM were examined for volume, thickness, and dosimetric changes across treatment with the results correlated to symptom group. Anatomical evaluation indicated the PCM thickness increased more during treatment for patients with dysphagia, with base of C2 vertebrae (p = 0.04) and superior-inferior middle PCM (p = 0.01) thicknesses indicating a 1.0–1.5 mm increase. The planned and delivered mean dose and DVH metrics to PCM and CPM were found to be within random error measured for the dose accumulation, indicating delivered and planned dose are equivalent. The PCM and CPM organs were found to lie approximately 5 mm closer to high dose gradients in patients exhibiting dysphagia. The volume, thickness, and high dose gradient metrics may be useful metrics to identify patients at risk of late patient-reported dysphagia.

Nur mit Berechtigung zugänglich

Pulte D, Brenner H. Changes in survival in head and neck cancers in the late 20th and early 21st century: a period analysis. Oncologist. 2010;15:994–1001. https://doi.org/10.1634/theoncologist.2009-0289.CrossRefPubMedPubMedCentral

Osborn J, Radiography. W.B. Saunders Ltd. 73–6. https://doi.org/10.1016/j.radi.2016.08.008.

Gawryszuk A, Bijl HP, Holwerda M, Halmos GB, Wedman J, Witjes MJH, et al. Functional swallowing units (FSUs) as organs-at-risk for radiotherapy. PART 1: physiology and anatomy. Radiother Oncol. 2019;130:62–7. https://doi.org/10.1016/j.radonc.2018.10.028.CrossRefPubMed

Okuni I, Otsubo Y, Ebihara S. Molecular and neural mechanism of Dysphagia due to Cancer. Int J Mol Sci. 2021;22. https://doi.org/10.3390/ijms22137033.

Feng FY, Kim HM, Lyden TH, Haxer MJ, Feng M, Worden FP, et al. Intensity-modulated radiotherapy of head and neck cancer aiming to reduce dysphagia: early dose-effect relationships for the swallowing structures. Int J Radiat Oncol Biol Phys. 2007;68:1289–98. https://doi.org/10.1016/j.ijrobp.2007.02.049.CrossRefPubMed

Petkar I, Rooney K, Roe JWG, Patterson JM, Bernstein D, Tyler JM, et al. DARS: a phase III randomised multicentre study of dysphagia- optimised intensity- modulated radiotherapy (Do-IMRT) versus standard intensity- modulated radiotherapy (S-IMRT) in head and neck cancer. BMC Cancer. 2016;16:770. https://doi.org/10.1186/s12885-016-2813-0.CrossRefPubMedPubMedCentral

Ricchetti F, Wu B, McNutt T, Wong J, Forastiere A, Marur S, et al. Volumetric change of selected organs at risk during IMRT for oropharyngeal cancer. Int J Radiat Oncol Biol Phys. 2011;80:161–8. https://doi.org/10.1016/j.ijrobp.2010.01.071.CrossRefPubMed

Christianen MEMC, Schilstra C, Beetz I, Muijs CT, Chouvalova O, Burlage FR, et al. Predictive modelling for swallowing dysfunction after primary (chemo)radiation: results of a prospective observational study. Radiother Oncol. 2012;105:107–14. https://doi.org/10.1016/j.radonc.2011.08.009.CrossRefPubMed

Marks LB, Yorke ED, Jackson A, ten Haken RK, Constine LS, Eisbruch A, et al. Use of normal tissue complication probability models in the clinic. Int J Radiat Oncol Biol Phys. 2010;76:S10–9. https://doi.org/10.1016/j.ijrobp.2009.07.1754.CrossRefPubMedPubMedCentral

10.

Ursino S, Calistri E, De Felice F, Bonomo P, Desideri I, Franco P, et al. Patient-reported outcomes after swallowing (SWOARs)-Sparing IMRT in Head and Neck cancers: primary results from a prospective study endorsed by the Head and Neck Study Group (HNSG) of the Italian Association of Radiotherapy and Clinical Oncology (AIRO). Dysphagia Springer. 2023;38:159–70. https://doi.org/10.1007/s00455-022-10434-4.CrossRef

11.

Dale T, Hutcheson K, Mohamed ASR, Lewin JS, Gunn GB, Rao AUK, et al. Beyond mean pharyngeal constrictor dose for beam path toxicity in non-target swallowing muscles: dose–volume correlates of chronic radiation-associated dysphagia (RAD) after oropharyngeal intensity modulated radiotherapy. Radiother Oncol. 2016;118:304–14. https://doi.org/10.1016/j.radonc.2016.01.019.CrossRef

12.

Hutcheson KA, Nurgalieva Z, Zhao H, Gunn GB, Giordano SH, Bhayani MK et al. (2019) Two-year prevalence of dysphagia and related outcomes in head and neck cancer survivors: An updated SEER-Medicare analysis. Head and Neck. John Wiley & Sons, Ltd. 41:479–87. https://doi.org/10.1002/hed.25412.

13.

Nevens D, Goeleven A, Duprez F, Laenen A, Dejaeger E, De Neve W, et al. Correlation of patient- and physician-scored Dysphagia with videofluoroscopies in patients treated with Radiotherapy for Head and Neck Cancer. Dysphagia Springer New York LLC. 2018;33:684–90. https://doi.org/10.1007/s00455-018-9888-5.CrossRef

14.

Wishart LR, Harris GB, Cassim N, Alimin S, Liao T, Brown B, et al. Association between objective ratings of swallowing and Dysphagia-Specific Quality of Life in patients receiving (Chemo)radiotherapy for Oropharyngeal Cancer. Dysphagia Springer. 2022;37:1014–21. https://doi.org/10.1007/s00455-021-10364-7.CrossRef

15.

Goepfert RP, Lewin JS, Barrow MP, Gunn GB, Fuller CD, Beadle BM, et al. Long-Term, prospective performance of the MD Anderson Dysphagia Inventory in Low-Intermediate Risk Oropharyngeal Carcinoma after Intensity Modulated Radiation Therapy. Int J Radiat Oncol Biol Phys. 2017;97:700–8. https://doi.org/10.1016/j.ijrobp.2016.06.010.CrossRefPubMed

16.

Chen A, Frankowski R, Bishop-Leone J, Hebert T, Leyk S, Lewin J, et al. The Development and Validation of a Dysphagia-Specific Quality-of-life questionnaire for patients with Head and Neck Cancer: the M. D. Anderson Dysphagia Inventory. Archives Otolaryngology–Head Neck Surg. 2001;127:870–6. https://jamanetwork.com/journals/jamaotolaryngology/article-abstract/482382.

17.

Grant S, Kamal M, Mohamed ASR, Zaveri J, Barrow MP, Gunn GB, et al. Single-item discrimination of quality-of-life-altering dysphagia among 714 long-term oropharyngeal cancer survivors: comparison of patient-reported outcome measures of swallowing. Cancer. 2019;125:1654–64. https://doi.org/10.1002/cncr.31957.CrossRefPubMed

18.

Kumarasiri A, Siddiqui F, Liu C, Yechieli R, Shah M, Pradhan D et al. (2014) Deformable image registration based automatic CT-to-CT contour propagation for head and neck adaptive radiotherapy in the routine clinical setting. Medical Physics. AAPM - American Association of Physicists in Medicine. 41:121712. https://doi.org/10.1118/1.4901409.

19.

Weppler S, Schinkel C, Kirkby C, Smith W. Lasso logistic regression to derive workflow-specific algorithm performance requirements as demonstrated for head and neck cancer deformable image registration in adaptive radiation therapy. Phys Med Biol. 2020;65:195013. https://doi.org/10.1088/1361-6560/ab9fc8.CrossRefPubMed

20.

Hinther A, Samson N, Lau H, Quon H, Banerjee R, Lysack JT, et al. Volumetric changes in pharyngeal structures following head and neck cancer chemoradiation therapy. Laryngoscope. 2020;130:597–602. https://doi.org/10.1002/lary.28164.CrossRefPubMed

21.

Kumarasiri A, Liu C, Kamal M, Fraser C, Brown S, Chetty IJ, et al. Changes in pharyngeal constrictor volumes during head and neck radiation therapy: implications for dose delivery. J Cancer Res Ther. 2017;13:218–23. https://doi.org/10.4103/0973-1482.183176.CrossRefPubMed

22.

Eisbruch A, Schwartz M, Rasch C, Vineberg K, Damen E, van As CJ, et al. Dysphagia and aspiration after chemoradiotherapy for head-and-neck cancer: which anatomic structures are affected and can they be spared by IMRT? Int J Radiat Oncol Biol Phys. 2004;60:1425–39. https://doi.org/10.1016/j.ijrobp.2004.05.050.CrossRefPubMed

23.

Popovtzer A, Cao Y, Feng FY, Eisbruch A. Anatomical changes in the pharyngeal constrictors after chemo-irradiation of head and neck cancer and their dose-effect relationships: MRI-based study. Radiother Oncol. 2009;93:510–5. https://doi.org/10.1016/j.radonc.2009.05.013.CrossRefPubMedPubMedCentral

24.

Bentzen SM, Constine LS, Deasy JO, Eisbruch A, Jackson A, Marks LB, et al. Quantitative analyses of normal tissue effects in the clinic (QUANTEC): an introduction to the scientific issues. Int J Radiat Oncol Biol Phys. 2010;76:S3–9. https://doi.org/10.1016/j.ijrobp.2009.09.040.CrossRefPubMedPubMedCentral

25.

Duffy O, Forde E, Leech M. The dilemma of parotid gland and pharyngeal constrictor muscles preservation-Is daily online image guidance required? A dosimetric analysis. Med Dosim. 2017;42:24–30. https://doi.org/10.1016/j.meddos.2016.10.003.CrossRefPubMed

26.

Meheissen MAM, Mohamed ASR, Kamal M, Hernandez M, Volpe S, Elhalawani H, et al. A prospective longitudinal assessment of MRI signal intensity kinetics of non-target muscles in patients with advanced stage oropharyngeal cancer in relationship to radiotherapy dose and post-treatment radiation-associated dysphagia: preliminary findings. Radiother Oncol. 2019;130:46–55. https://doi.org/10.1016/j.radonc.2018.08.010.CrossRef

27.

Tsai CJ, Jackson A, Setton J, Riaz N, McBride S, Leeman J, et al. Modeling dose response for late Dysphagia in patients with Head and Neck Cancer in the modern era of definitive chemoradiation. JCO Clin Cancer Inf. 2017;1:1–7. https://doi.org/10.1200/CCI.17.00070.CrossRef

28.

Eisbruch A, Kim HM, Feng FY, Lyden TH, Haxer MJ, Feng M, et al. Chemo-IMRT of oropharyngeal cancer aiming to reduce dysphagia: swallowing organs late complication probabilities and dosimetric correlates. Int J Radiat Oncol Biol Phys. 2011;81:e93–9. https://doi.org/10.1016/j.ijrobp.2010.12.067.CrossRefPubMedPubMedCentral

29.

Hutchison AR, Wishart LR, Brown B, Ward EC, Hargrave C, Brown E, et al. Exploring the interplay between Radiotherapy Dose and physiological changes in the swallowing mechanism in patients undergoing (Chemo)radiotherapy for Oropharynx Cancer. Dysphagia Springer. 2022;37:567–77. https://doi.org/10.1007/s00455-021-10307-2.CrossRef

30.

Jin X, Hu W, Shang H, Han C, Yi J, Zhou Y, et al. CBCT-based volumetric and dosimetric variation evaluation of volumetric modulated arc radiotherapy in the treatment of nasopharyngeal cancer patients. Radiation Oncol BioMed Cent. 2013;8:279. https://doi.org/10.1186/1748-717X-8-279.CrossRef

31.

Hutcheson KA, Barrow MP, Lisec A, Barringer DA, Gries K, Lewin JS. What is a clinically relevant difference in MDADI scores between groups of head and neck cancer patients? Laryngoscope. 2016;126:1108–13. https://doi.org/10.1002/lary.25778.CrossRefPubMed

32.

Andersen ES, Noe KØ, Sørensen TS, Nielsen SK, Fokdal L, Paludan M, et al. Simple DVH parameter addition as compared to deformable registration for bladder dose accumulation in cervix cancer brachytherapy. Radiotherapy Oncol Elsevier. 2013;107:52–7. https://doi.org/10.1016/j.radonc.2013.01.013.CrossRef

33.

Weppler S, Quon H, Schinkel C, Ddamba J, Harjai N, Vigal C, et al. Determining clinical patient selection guidelines for Head and Neck Adaptive Radiation Therapy using Random Forest Modelling and a Novel Simplification Heuristic. Front Oncol Front. 2021;0:1889. https://doi.org/10.3389/FONC.2021.650335.CrossRef

34.

Harris CR, Millman KJ, van der Walt SJ, Gommers R, Virtanen P, Cournapeau D et al. (2020) Array programming with NumPy. Nature. Nature Research. p. 357–62. https://doi.org/10.1038/s41586-020-2649-2.

35.

Yaniv Z, Lowekamp BC, Johnson HJ, Beare R. SimpleITK Image-Analysis notebooks: a Collaborative Environment for Education and Reproducible Research. Journal of Digital Imaging. Springer New York LLC. 2018;31:290–303. https://doi.org/10.1007/s10278-017-0037-8.CrossRef

36.

Ranganathan P, Pramesh CS, Buyse M. Common pitfalls in statistical analysis: the perils of multiple testing. Perspect Clin Res. 2016;7. https://doi.org/10.4103/2229-3485.179436.

37.

Langendijk JA, Doornaert P, Rietveld DHF, Verdonck-de Leeuw IM, René Leemans C, Slotman BJ. A predictive model for swallowing dysfunction after curative radiotherapy in head and neck cancer. Radiother Oncol. 2009;90:189–95. https://doi.org/10.1016/j.radonc.2008.12.017.CrossRefPubMed

Titel: Dysphagia in Head and Neck Radiotherapy: The Influence of Pharyngeal Constrictor Anatomy and Dosimetry
verfasst von: Owen Paetkau
Sarah Weppler
Jaime Kwok
Harvey C. Quon
Wendy Smith
Ekaterina Tchistiakova
Charles Kirkby
Publikationsdatum: 16.05.2024
Verlag: Springer US
Erschienen in: Dysphagia
Print ISSN: 0179-051X
Elektronische ISSN: 1432-0460
DOI: https://doi.org/10.1007/s00455-024-10705-2

Neu im Fachgebiet HNO

Erhebliches Risiko für Kehlkopfkrebs bei mäßiger Dysplasie

29.05.2024 Larynxkarzinom Nachrichten

Fast ein Viertel der Personen mit mäßig dysplastischen Stimmlippenläsionen entwickelt einen Kehlkopftumor. Solche Personen benötigen daher eine besonders enge ärztliche Überwachung.

Hörschwäche erhöht Demenzrisiko unabhängig von Beta-Amyloid

29.05.2024 Hörstörungen Nachrichten

Hört jemand im Alter schlecht, nimmt das Hirn- und Hippocampusvolumen besonders schnell ab, was auch mit einem beschleunigten kognitiven Abbau einhergeht. Und diese Prozesse scheinen sich unabhängig von der Amyloidablagerung zu ereignen.

„Übersichtlicher Wegweiser“: Lauterbachs umstrittener Klinik-Atlas ist online

17.05.2024 Klinik aktuell Nachrichten

Sie sei „ethisch geboten“, meint Gesundheitsminister Karl Lauterbach: mehr Transparenz über die Qualität von Klinikbehandlungen. Um sie abzubilden, lässt er gegen den Widerstand vieler Länder einen virtuellen Klinik-Atlas freischalten.

Betalaktam-Allergie: praxisnahes Vorgehen beim Delabeling

16.05.2024 Pädiatrische Allergologie Nachrichten

Die große Mehrheit der vermeintlichen Penicillinallergien sind keine. Da das „Etikett“ Betalaktam-Allergie oft schon in der Kindheit erworben wird, kann ein frühzeitiges Delabeling lebenslange Vorteile bringen. Ein Team von Pädiaterinnen und Pädiatern aus Kanada stellt vor, wie sie dabei vorgehen.

Update HNO

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.

Newsletter bestellen

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

Dysphagia in Head and Neck Radiotherapy: The Influence of Pharyngeal Constrictor Anatomy and Dosimetry

Abstract

Neu im Fachgebiet HNO

Erhebliches Risiko für Kehlkopfkrebs bei mäßiger Dysplasie

Hörschwäche erhöht Demenzrisiko unabhängig von Beta-Amyloid

„Übersichtlicher Wegweiser“: Lauterbachs umstrittener Klinik-Atlas ist online

Betalaktam-Allergie: praxisnahes Vorgehen beim Delabeling

Update HNO

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Neu im Fachgebiet HNO

Erhebliches Risiko für Kehlkopfkrebs bei mäßiger Dysplasie

Hörschwäche erhöht Demenzrisiko unabhängig von Beta-Amyloid

„Übersichtlicher Wegweiser“: Lauterbachs umstrittener Klinik-Atlas ist online

Betalaktam-Allergie: praxisnahes Vorgehen beim Delabeling

Update HNO